Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
Description | Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes. |
Targets&IC50 | rat pancreatic lipase:54.8 nM, human pancreatic lipase:5.95 nM |
Synonyms | 新利司他, ATL-962 |
Molecular Weight | 401.591 |
Formula | C25H39NO3 |
CAS No. | 282526-98-1 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
H2O: Insoluble
DMSO: Insoluble
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cetilistat 282526-98-1 代谢 Lipid ATL962 ATL-962 ATL 962 high-fat diet cholesterol Inhibitor anti-obesity pancreatic lipase inhibit inhibitor